Nvidia-backed Iambic stock is up 16% in Nasdaq debut after $150 million IPO
Quartz·
qz.comThe San Diego drug developer priced its IPO at $16 per share and plans to direct most of the proceeds to its cancer drug pipeline
qz.comThe San Diego drug developer priced its IPO at $16 per share and plans to direct most of the proceeds to its cancer drug pipeline
Quick actions
Last updated 1 day ago
Last updated 1 day ago